- All sections
- C - Chemistry; metallurgy
- C12N - Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media
- C12N 9/16 - Hydrolases (3.) acting on ester bonds (3.1)
Patent holdings for IPC class C12N 9/16
Total number of patents in this class: 3062
10-year publication summary
206
|
283
|
249
|
249
|
286
|
289
|
284
|
230
|
204
|
74
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Novozymes A/S | 3314 |
89 |
The Regents of the University of California | 18943 |
52 |
DSM IP Assets B.V. | 5856 |
51 |
Genomatica, Inc. | 514 |
50 |
CJ Cheiljedang Corporation | 2964 |
42 |
Modernatx, Inc. | 1181 |
38 |
The General Hospital Corporation | 4517 |
36 |
Danisco US Inc. | 1045 |
34 |
Alexion Pharmaceuticals, Inc. | 606 |
33 |
Corbion Biotech, Inc. | 141 |
33 |
New England BioLabs, Inc. | 460 |
32 |
Kao Corporation | 4843 |
25 |
Takeda Pharmaceutical Company Limited | 2961 |
25 |
JCR Pharmaceuticals Co., Ltd. | 206 |
25 |
The Trustees of the University of Pennsylvania | 4122 |
20 |
Wisconsin Alumni Research Foundation | 3774 |
19 |
Snipr Technologies Limited | 50 |
19 |
President and Fellows of Harvard College | 5792 |
18 |
Duke University | 2872 |
18 |
Yale University | 2204 |
18 |
Other owners | 2385 |